Back to top
more

Cigna Group (CI)

(Delayed Data from NYSE)

$338.71 USD

338.71
2,010,194

-0.55 (-0.16%)

Updated May 17, 2024 04:00 PM ET

After-Market: $338.74 +0.03 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (71 out of 249)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Cigna (CI) Beats on Q4 Earnings & Revenues

by Zacks Equity Research

Cigna surpassed the earnings estimate. Our consensus called for earning per share of $1.74, and the company reported earnings of $1.87 per share. Earnings per share were, however, flat year over year.

    Can Cigna (CI) Sustain its Earnings Surprise Streak in Q4? (Revised)

    by Zacks Equity Research

    We expect Cigna Corp. (CI) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 2.

      Should You Sell Cigna (CI) Before Earnings?

      by Zacks Equity Research

      Cigna (CI) could be an interesting stock for investors ahead of earnings, as it has a positive ESP and a favorable Zacks Rank.

        Can Cigna (CI) Sustain its Earnings Surprise Streak in Q4?

        by Zacks Equity Research

        We expect Cigna Corp. (CI) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 2.

          The Hartford (HIG): What's in Store this Earnings Season?

          by Zacks Equity Research

          The Hartford Financial Services Group, Inc. (HIG) will release fourth-quarter 2016 financial results on Feb 2 after the closing bell.

            What's in Store for XL Group (XL) this Earnings Season?

            by Zacks Equity Research

            XL Group Ltd (XL) is slated to report fourth-quarter 2016 results on Feb 1, after the market closes.

              Aetna's Merger with Humana Foiled by Regulators, Stock Down

              by Zacks Equity Research

              Federal authorities reviewing the proposed Aetna Inc. (AET) and Humana Inc. (HUM) mega merger have now blocked the deal.

                Anthem Extends Alliance with Inovalon, Boosts Customer Value

                by Zacks Equity Research

                Leading U.S.-based Health Maintenance Organization (HMO), Anthem Inc. (ANTM), recently declared a multi-year extension of its partnership with Inovalon Holdings, Inc. (INOV).

                  Aetna Continues to Grow Business, Merger Remains Uncertain

                  by Zacks Equity Research

                  On Dec 27, we issued an updated research report on Aetna Inc. (AET).

                    Why UnitedHealth (UNH) Stands Tall Amid All the Noise

                    by Zacks Equity Research

                    UnitedHealth (UNH) has been able to beat all kinds of industry odds to emerge as a winner.

                      Aetna CEO Calls Pulling out of ACA Exchanges 'Good Business'

                      by Zacks Equity Research

                      Aetna Inc. (AET) recently came under fire for having allegedly pulled out of Affordable Care Act (ACA) exchanges in 11 states, including the areas covered by the Justice Department lawsuit, in a bid to avoid antitrust claims.

                        Anthem's Membership Growth Impressive, High Debt a Drag

                        by Zacks Equity Research

                        On Dec 9, 2016, we have issued an updated research report on Anthem Inc. (ANTM).

                          Tanuka De headshot

                          6 Insurers Set to Counter Cat Loss with Q2 Earnings Beat

                          by Tanuka De

                          insurers in this well-capitalized industry remain well poised on their expanded and diversified product and service portfolio.

                            Health Insurers Troubled by Election, Public Exchanges

                            by Zacks Equity Research

                            U.S. health plans are expected to operate in a lowered margin environment. Some -- especially the smaller ones -- may not survive.